Literature DB >> 7952801

Presentation of the intrasubject coefficient of variation for sample size planning in bioequivalence studies.

D Hauschke1, W V Steinijans, E Diletti, R Schall, H G Luus, M Elze, H Blume.   

Abstract

Bioequivalence studies are generally performed as crossover studies and, therefore, information on the intrasubject coefficient of variation is needed for sample size planning. Unfortunately, this information is usually not presented in publications on bioequivalence studies, and only the pooled inter- and intrasubject coefficient of variation for either test or reference formulation is reported. Thus, the essential information for sample size planning of future studies is not made available to other researchers. In order to overcome such shortcomings, the presentation of results from bioequivalence studies should routinely include the intrasubject coefficient of variation. For the relevant coefficients of variation, theoretical background together with modes of calculation and presentation are given in this communication with particular emphasis on the multiplicative model.

Mesh:

Year:  1994        PMID: 7952801

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  3 in total

1.  Two-Stage Adaptive Designs for Three-Treatment Bioequivalence Studies.

Authors:  Michael J Grayling; Adrian P Mander; James M S Wason
Journal:  Stat Biopharm Res       Date:  2019-09-06       Impact factor: 1.452

2.  Innovative Design and Analysis for PK/PD Biosimilar Bridging Studies with Multiple References.

Authors:  Fuyu Song; Xin Zheng; Yujia Wang; Shein-Chung Chow; Hongqiang Sun
Journal:  AAPS J       Date:  2021-11-30       Impact factor: 4.009

3.  Individualizing therapy - in search of approaches to maximize the benefit of drug treatment (II).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.